Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TaiDoc TechnologyTPE:4736 72 Debt-to-Equity is 0.09 as of Jun. 2026, which is 36% below its 10-year median of 0.14. GuruFocus rates TPE:4736 with a GF Score™ of 72/100 and a GF Value™ of NT$111.77 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 697 Medical Devices & Instruments companies, TaiDoc Technology ranks better than 71.31% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for TaiDoc Technology's Debt-to-Equity or its related term are showing as below:
TPE:4736'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.07 Med: 0.14 Max: 0.79
Current: 0.09
During the past 13 years, the highest Debt-to-Equity Ratio of TaiDoc Technology was 0.79. The lowest was 0.07. And the median was 0.14.
TPE:4736's Debt-to-Equity is ranked better than 71.31% of 697
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs TPE:4736: 0.09
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
TaiDoc Technology Debt-to-Equity Related Terms
TaiDoc Technology Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for TaiDoc Technology's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4736 vs ABT, SYK, MDT: Debt-to-Equity Comparison
For the Medical Devices subindustry, TaiDoc Technology's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TaiDoc Technology Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TaiDoc Technology's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where TaiDoc Technology's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TaiDoc Technology (TPE:4736) has a Debt-to-Equity of 0.09 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on TaiDoc Technology and its competitors. This is 36% below median its historical median of 0.14. Over the past decade, TaiDoc Technology's Debt-to-Equity has ranged from 0.07 to 0.79. According to the industry distribution chart, TaiDoc Technology ranks #200 out of 697 companies in the Medical Devices & Instruments industry, placing it in the top 28.7%.
Is TaiDoc Technology's Debt-to-Equity too high?
TaiDoc Technology's current Debt-to-Equity of 0.09 is 36% below median its 10-year median of 0.14. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 0.79. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. TaiDoc Technology's value of 0.09 is 60.9% below this industry median. Based on the distribution chart, TaiDoc Technology ranks #200 out of 697 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, TaiDoc Technology has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TaiDoc Technology's Debt-to-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, TaiDoc Technology ranks #200 out of 697 companies for Debt-to-Equity. This puts TaiDoc Technology in the upper half of its industry. The industry median Debt-to-Equity is 0.23. TaiDoc Technology's value of 0.09 is 60.9% below this benchmark. Historically, TaiDoc Technology's own Debt-to-Equity has ranged from 0.07 to 0.79 over the past decade. While the company's 10-year median is 0.14 vs. the industry median of 0.23, TaiDoc Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TaiDoc Technology's current Debt-to-Equity of 0.09 is 60.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on TaiDoc Technology and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TaiDoc Technology's current Debt-to-Equity is 0.09, which is 36% below median its own 10-year median of 0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiDoc Technology stock overvalued right now?
Based on GuruFocus' analysis, TaiDoc Technology (TPE:4736) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$111.77, compared to a current price of NT$124.50 — trading 11.4% above its estimated fair value. The current Debt-to-Equity is 0.09, which is 36% below median its 10-year median of 0.14 and 60.9% below the Medical Devices & Instruments industry median of 0.23. TaiDoc Technology's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For TaiDoc Technology (TPE:4736), the current Debt-to-Equity is 0.09 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TaiDoc Technology (TPE:4736) Overvalued in 2026?
Based on GuruFocus' analysis, TaiDoc Technology stock appears to be overvalued.
The current stock price of NT$124.50 is trading 11.4% above its estimated GF Value™ of NT$111.77.
GuruFocus considers TaiDoc Technology to be Modestly Overvalued.
Key valuation signals for TPE:4736:
Debt-to-Equity: 0.09 (36% below median its 10-year median of 0.14)
GF Value™: NT$111.77 vs. price of NT$124.50 (11.4% above fair value)
Industry Position: 60.9% below the Medical Devices & Instruments median (#200 of 697)
No single metric tells the full story. See the TPE:4736 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TaiDoc Technology Corp is engaged in the research and development, manufacture, and sales of various electronics components and medical devices. Its products and services include In Vitro Diagnostic, Medical Device, and TeleHealth. It has three segments: Manufacturing of Medical Devices, Precision Finishing Division, and Sales of Medical Devices. It derives the majority of its revenue from the Manufacturing of Medical Devices. Geographically, the company derives its key revenue from Europe and the rest from the Americas, the Middle East, Asia, Taiwan, and others.
72GF Score
Get the complete analysis for TPE:4736
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4736 has been successfully added to your 
